Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome

Multiple endocrine neoplasia (MEN) type 1 syndrome is an autosomal dominant disorder caused by germline mutations in MEN1 gene, characterized by tumours in endocrine and nonendocrine organs. Giant prolactinoma is defined as tumours larger than 40mm with very high prolactin secretion. We report two u...

Full description

Saved in:
Bibliographic Details
Main Authors: Chandrika Jayakanthi Subasinghe, Noel Somasundaram, Pathmanathan Sivatharshya, Lalana Devi Ranasinghe, Márta Korbonits
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2018/2875074
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545837105807360
author Chandrika Jayakanthi Subasinghe
Noel Somasundaram
Pathmanathan Sivatharshya
Lalana Devi Ranasinghe
Márta Korbonits
author_facet Chandrika Jayakanthi Subasinghe
Noel Somasundaram
Pathmanathan Sivatharshya
Lalana Devi Ranasinghe
Márta Korbonits
author_sort Chandrika Jayakanthi Subasinghe
collection DOAJ
description Multiple endocrine neoplasia (MEN) type 1 syndrome is an autosomal dominant disorder caused by germline mutations in MEN1 gene, characterized by tumours in endocrine and nonendocrine organs. Giant prolactinoma is defined as tumours larger than 40mm with very high prolactin secretion. We report two unrelated Sri Lankan patients (8-year-old boy and a 20-year-old female) who presented with giant prolactinomas with mass effects of the tumours. The female patient showed complete response to medical therapy, while the boy developed recurrent resistant prolactinoma needing surgery and radiotherapy. During follow-up, both developed pancreatic neuroendocrine tumours. Genetic analysis revealed that one was heterozygous for a nonsense mutation and other for missense mutation in MEN1 gene. Screening confirmed familial MEN-1 syndrome in their families. High clinical suspicion upon unusual clinical presentation prompted genetic evaluation in these patients and detection of MEN1 gene mutation. Pituitary adenomas in children with MEN-1 syndrome are larger tumours with higher rates of treatment resistance. This report emphasizes importance of screening young patients with giant prolactinoma for MEN-1 syndrome and arranging long-term follow-up for them expecting variable treatment outcomes. Sri Lanka requires further studies to describe the genotypic-phenotypic variability of MEN-1 syndrome in this population.
format Article
id doaj-art-2d278248ae0d4527a98fe33dd0518263
institution Kabale University
issn 2090-6501
2090-651X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-2d278248ae0d4527a98fe33dd05182632025-02-03T07:24:36ZengWileyCase Reports in Endocrinology2090-65012090-651X2018-01-01201810.1155/2018/28750742875074Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 SyndromeChandrika Jayakanthi Subasinghe0Noel Somasundaram1Pathmanathan Sivatharshya2Lalana Devi Ranasinghe3Márta Korbonits4Endocrinology Unit, National Hospital of Sri Lanka, Colombo, Sri LankaEndocrinology Unit, National Hospital of Sri Lanka, Colombo, Sri LankaEndocrinology Unit, National Hospital of Sri Lanka, Colombo, Sri LankaEndocrinology Unit, National Hospital of Sri Lanka, Colombo, Sri LankaDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UKMultiple endocrine neoplasia (MEN) type 1 syndrome is an autosomal dominant disorder caused by germline mutations in MEN1 gene, characterized by tumours in endocrine and nonendocrine organs. Giant prolactinoma is defined as tumours larger than 40mm with very high prolactin secretion. We report two unrelated Sri Lankan patients (8-year-old boy and a 20-year-old female) who presented with giant prolactinomas with mass effects of the tumours. The female patient showed complete response to medical therapy, while the boy developed recurrent resistant prolactinoma needing surgery and radiotherapy. During follow-up, both developed pancreatic neuroendocrine tumours. Genetic analysis revealed that one was heterozygous for a nonsense mutation and other for missense mutation in MEN1 gene. Screening confirmed familial MEN-1 syndrome in their families. High clinical suspicion upon unusual clinical presentation prompted genetic evaluation in these patients and detection of MEN1 gene mutation. Pituitary adenomas in children with MEN-1 syndrome are larger tumours with higher rates of treatment resistance. This report emphasizes importance of screening young patients with giant prolactinoma for MEN-1 syndrome and arranging long-term follow-up for them expecting variable treatment outcomes. Sri Lanka requires further studies to describe the genotypic-phenotypic variability of MEN-1 syndrome in this population.http://dx.doi.org/10.1155/2018/2875074
spellingShingle Chandrika Jayakanthi Subasinghe
Noel Somasundaram
Pathmanathan Sivatharshya
Lalana Devi Ranasinghe
Márta Korbonits
Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
Case Reports in Endocrinology
title Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
title_full Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
title_fullStr Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
title_full_unstemmed Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
title_short Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
title_sort giant prolactinoma of young onset a clue to diagnosis of men 1 syndrome
url http://dx.doi.org/10.1155/2018/2875074
work_keys_str_mv AT chandrikajayakanthisubasinghe giantprolactinomaofyoungonsetacluetodiagnosisofmen1syndrome
AT noelsomasundaram giantprolactinomaofyoungonsetacluetodiagnosisofmen1syndrome
AT pathmanathansivatharshya giantprolactinomaofyoungonsetacluetodiagnosisofmen1syndrome
AT lalanadeviranasinghe giantprolactinomaofyoungonsetacluetodiagnosisofmen1syndrome
AT martakorbonits giantprolactinomaofyoungonsetacluetodiagnosisofmen1syndrome